Literature DB >> 15136721

Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine.

Evgeny A Budygin1, Mark S Brodie, Tatyana D Sotnikova, Yolanda Mateo, Carrie E John, Michel Cyr, Raul R Gainetdinov, Sara R Jones.   

Abstract

The interaction of amphetamine (AMPH) with the dopamine (DA) transporter (DAT) is thought to be critically important for the DA-elevating actions of this drug. It is commonly believed that DA elevations are involved in the rewarding/reinforcing properties of AMPH and other drugs of abuse. Here, we found that DAT deletion did not eliminate the rewarding effects of AMPH as measured by conditioned place preference (CPP). In fact, mice in which the DAT gene has been deleted (DAT-KO mice) exhibited AMPH-induced CPP for many weeks after the time when extinction occurred in WT mice. Moreover, systemic AMPH still increased extracellular DA in the nucleus accumbens (NAc) of mice lacking the DAT, although local infusion of AMPH into the NAc did not have this effect. By using voltammetry in NAc slices, we found that AMPH did not decrease the rate of DA clearance. The rate of ventral tegmental area DA neuron firing was dramatically inhibited by AMPH in brain slices from WT mice, but there was no inhibition of firing in DAT-KO mice. AMPH-induced CPP was abolished by pretreatment with WAY-100635, a serotonin 5-HT(1A) receptor antagonist, in DAT-KO mice, but the drug did not change AMPH place preference in WT mice. Therefore, despite the absence of the DAT, AMPH displays rewarding effects and causes an increase in extracellular DA in the NAc of DAT-KO mice, acting indirectly in this case. The 5-HT system may be involved in the rewarding effects of AMPH in these mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136721      PMCID: PMC419683          DOI: 10.1073/pnas.0401418101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.

Authors:  C Saunders; J V Ferrer; L Shi; J Chen; G Merrill; M E Lamb; L M Leeb-Lundberg; L Carvelli; J A Javitch; A Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.

Authors:  F S Hall; X F Li; I Sora; F Xu; M Caron; K P Lesch; D L Murphy; G R Uhl
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

3.  Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.

Authors:  Y Schmitz; C J Lee; C Schmauss; F Gonon; D Sulzer
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

4.  Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions.

Authors:  Christina A Schad; Joseph B Justice; Stephen G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  2002-03       Impact factor: 4.030

5.  5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

Authors:  Grégory Porras; Vincenzo Di Matteo; Claudia Fracasso; Guillaume Lucas; Philippe De Deurwaerdère; Silvio Caccia; Ennio Esposito; Umberto Spampinato
Journal:  Neuropsychopharmacology       Date:  2002-03       Impact factor: 7.853

6.  A role for presynaptic mechanisms in the actions of nomifensine and haloperidol.

Authors:  P A Garris; E A Budygin; P E M Phillips; B J Venton; D L Robinson; B P Bergstrom; G V Rebec; R M Wightman
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

7.  Increased ethanol excitation of dopaminergic neurons of the ventral tegmental area after chronic ethanol treatment.

Authors:  Mark S Brodie
Journal:  Alcohol Clin Exp Res       Date:  2002-07       Impact factor: 3.455

8.  Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons.

Authors:  Susan L Ingram; Balakrishna M Prasad; Susan G Amara
Journal:  Nat Neurosci       Date:  2002-10       Impact factor: 24.884

9.  Acute cocaine differentially alters accumbens and striatal dopamine clearance in low and high cocaine locomotor responders: behavioral and electrochemical recordings in freely moving rats.

Authors:  Jilla Sabeti; Greg A Gerhardt; Nancy R Zahniser
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

10.  Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine.

Authors:  Grégory Porras; Vincenzo Di Matteo; Philippe De Deurwaerdère; Ennio Esposito; Umberto Spampinato
Journal:  Neuropharmacology       Date:  2002-12       Impact factor: 5.250

View more
  28 in total

1.  Enhanced tyrosine hydroxylase phosphorylation in the nucleus accumbens and nucleus tractus solitarius-A2 cell group after morphine-conditioned place preference.

Authors:  A González-Cuello; L Mora; J M Hidalgo; N Meca; C Lasheras; M V Milanés; M L Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-06       Impact factor: 3.000

2.  Adolescent social defeat increases adult amphetamine conditioned place preference and alters D2 dopamine receptor expression.

Authors:  A R Burke; M J Watt; G L Forster
Journal:  Neuroscience       Date:  2011-09-10       Impact factor: 3.590

3.  Chemosensory cue conditioning with stimulants in a Caenorhabditis elegans animal model of addiction.

Authors:  Heather N Musselman; Bethany Neal-Beliveau; Richard Nass; Eric A Engleman
Journal:  Behav Neurosci       Date:  2012-06       Impact factor: 1.912

Review 4.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

5.  Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.

Authors:  Osamu Uchiumi; Yoshiyuki Kasahara; Asami Fukui; F Scott Hall; George R Uhl; Ichiro Sora
Journal:  Neuropharmacology       Date:  2012-07-15       Impact factor: 5.250

Review 6.  Dopamine transporter mutant animals: a translational perspective.

Authors:  Evgeniya V Efimova; Raul R Gainetdinov; Evgeny A Budygin; Tatyana D Sotnikova
Journal:  J Neurogenet       Date:  2016-03       Impact factor: 1.250

7.  Dopamine uptake inhibition is positively correlated with cocaine-induced stereotyped behavior.

Authors:  Evgeny A Budygin
Journal:  Neurosci Lett       Date:  2007-10-11       Impact factor: 3.046

Review 8.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

Review 9.  Advancing addiction treatment: what can we learn from animal studies?

Authors:  Peter H Wu; Kalynn M Schulz
Journal:  ILAR J       Date:  2012

10.  Amphetamine activates an amine-gated chloride channel to generate behavioral effects in Caenorhabditis elegans.

Authors:  Bryan D Safratowich; Chee Lor; Laura Bianchi; Lucia Carvelli
Journal:  J Biol Chem       Date:  2013-06-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.